Alain M Schoepfer (Alain Schoepfer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Gastroesophageal Reflux Disease

Endoscopic Submucosal Dissection

Top Venues

Alimentary pharmacology & therapeutics

Revue medicale suisse

This page only lists publications with an associated author ORCID identifier.

Publications

Meddy Dalex, Alain M Schoepfer, Jeanine Wakim El-Khoury
[Gastroesophageal reflux disease in 2024]. Revue medicale suisse 20 (884) (2024)
Ikuo Hirano, Ekaterina Safroneeva, Marie C Roumet, Gail M Comer, Gina Eagle, Alain M Schoepfer, Gary W Falk
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' reply. Alimentary pharmacology & therapeutics 51 (10) (2020)
Ikuo Hirano, Ekaterina Safroneeva, Marie C Roumet, Gail M Comer, Gina Eagle, Alain M Schoepfer, Gary W Falk
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 51 (8) (2020)
Ekaterina Safroneeva, Lukas Balsiger, David Hafner, Claudia E Kuehni, Marcel Zwahlen, Sven Trelle, Sébastien Godat, Luc Biedermann, Thomas Greuter, Stephan Vavricka, Alex Straumann, Alain M Schoepfer
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes. Alimentary pharmacology & therapeutics 48 (10) (2019)